September 10, 2025Diabetes Care

Real-Time Continuous Glucose Monitoring in Pregnancies With Gestational Diabetes: A Randomized Controlled Trial

View Full Paper

Ask AI

Bookmark

Authors

AVAmy Miyoshi ValentOregon Health & Science University MRMichaela C. RickertOregon Health & Science University CPChristian Huerta Pagan

Discussion

Member takes

Implication

Randomized controlled trial shows improved glucose time in range in pregnancies with gestational diabetes, indicating CGM's potential advantage over traditional monitoring methods.

Key Points

The real-time continuous glucose monitoring group achieved significantly higher percent time in range.
Participants using the Dexcom G6 CGM had a mean time in range of 93 minutes compared to 88 minutes for capillary blood glucose monitoring.
This open-label, single-center randomized controlled trial included 111 pregnant participants with gestational diabetes.
Findings suggest CGM may offer better glucose control, highlighting the need for further studies on outcomes.

Cite This Study

Valent et al. (2025) studied this question.

synapsesocial.com/papers/68c23e94b210217d64792aee https://doi.org/10.2337/dc25-0115

View Full Paper

Ask AI

Bookmark

Implication

Randomized controlled trial shows improved glucose time in range in pregnancies with gestational diabetes, indicating CGM's potential advantage over traditional monitoring methods.

Real-Time Continuous Glucose Monitoring in Pregnancies With Gestational Diabetes: A Randomized Controlled Trial

Discussion

Member takes

Implication

Key Points

Cite This Study

Real-Time Continuous Glucose Monitoring in Pregnancies With Gestational Diabetes: A Randomized Controlled Trial

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider